Forbes
In Forbes, BCG’s Michael Ringel discusses the rise of longevity biotechnology, a new branch of health care seeking to maximize the human lifespan. On the heels of the 9th Aging Research and Drug Discovery (ARDD) Meeting, at which he presented, Ringel explains how aging underpins many of the chronic diseases that burden human health. By more thoroughly examining the biology behind longevity, Ringel believes scientists can uncover treatments that prevent not just one, but multiple disorders.